001     305362
005     20251027132945.0
024 7 _ |a 10.1088/1361-6560/ae128f
|2 doi
024 7 _ |a pmid:41082905
|2 pmid
024 7 _ |a 0031-9155
|2 ISSN
024 7 _ |a 1361-6560
|2 ISSN
037 _ _ |a DKFZ-2025-02106
041 _ _ |a English
082 _ _ |a 530
100 1 _ |a Jensen, Mads Lykke
|0 0000-0001-9534-9034
|b 0
245 _ _ |a Achieving high-resolution spatial mapping of dose and linear energy transfer in ion-beam therapy.
260 _ _ |a Bristol
|c 2025
|b IOP Publ.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1761568142_3448744
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Med. Biol. 70 215008
520 _ _ |a Objective:We present a novel detector system capable of simultaneously obtaining two-dimensional (2D) dose and linear energy transfer (LET) maps from Al2O3films of sizes up to 190x190 mm2using optically stimulated luminescence (OSL). Approach:The system is based on the OSL from doped Al2O3films measured using pulsed stimulation and time-resolved OSL detection. The system was calibrated in proton,4He-, and12C-ion beams. The minimal detectable dose, response homogeneity, pixel cross-stimulation, and precision were also investigated. To demonstrate the system's performance, 2D maps of dose and LET of a proton Bragg curve were measured. Main results:The system was demonstrated to be capable of obtaining absorbed dose and LET 2D maps with a spatial resolution set to 1.0x1.0 mm2. The system was calibrated over a clinically relevant range of LET values and characterized through assessment of minimal detectable dose (<25 mGy), readout protocols, response homogeneity, precision, and relative detector efficiency. Dose and LET were found to be measurable with precisions of 3.2% and 10%, respectively. Significance:To our knowledge, this is the first passive detector system capable of measuring LET and dose simultaneously in 2D with a 1.0 mm2spatial resolution and no prior dose knowledge. Such properties are required to experimentally validate simulated dose and LET distributions in ion-beam therapy, paving the way for sub-mm mapping of radiation-induced relative biological effectiveness.
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a 2D mapping
|2 Other
650 _ 7 |a Dosimetry
|2 Other
650 _ 7 |a Ion-beam Therapy
|2 Other
650 _ 7 |a LET
|2 Other
650 _ 7 |a OSL
|2 Other
650 _ 7 |a Proton therapy
|2 Other
650 _ 7 |a Radiotherapy
|2 Other
700 1 _ |a Togno, Michele
|b 1
700 1 _ |a Muñoz, Iván Domingo
|b 2
700 1 _ |a Brons, Stephan
|0 0000-0002-4695-0816
|b 3
700 1 _ |a Jaekel, Oliver
|0 0000-0002-6056-9747
|b 4
700 1 _ |a Yukihara, Eduardo G
|0 0000-0002-4615-6698
|b 5
700 1 _ |a Christensen, Jeppe Brage
|0 0000-0002-6894-381X
|b 6
773 _ _ |a 10.1088/1361-6560/ae128f
|0 PERI:(DE-600)1473501-5
|n 21
|p 215008
|t Physics in medicine and biology
|v 70
|y 2025
|x 0031-9155
909 C O |p VDB
|o oai:inrepo02.dkfz.de:305362
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 0000-0002-6056-9747
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2025
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2024-12-27
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PHYS MED BIOL : 2022
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-27
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-27
920 1 _ |0 I:(DE-He78)E040-20160331
|k E040
|l E040 Med. Physik in der Strahlentherapie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E040-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21